$4.9B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | SRRK Scholar Rock Hldg Corp | 9.6M | −11.5% | $527M | 10.7% |
| 2 | KYMR Kymera Therapeutics Inc | 2.9M | −7.9% | $337M | 6.8% |
| 3 | ERAS Erasca Inc | 11.4M | +1.4% | $209M | 4.2% |
| 4 | MANE Veradermics Inc | 1.7M | +10.0% | $204M | 4.1% |
| 5 | TNGX Tango Therapeutics Inc | 6.2M | +9.2% | $193M | 3.9% |
| 6 | RVMD Revolution Medicines Inc | 900,000 | −19.0% | $169M | 3.4% |
| 7 | BCAX Bicara Therapeutics Inc | 5.6M | −3.4% | $166M | 3.4% |
| 8 | ARWR Arrowhead Pharmaceuticals In | 1.7M | +6.2% | $140M | 2.8% |
| 9 | ONC Beone Medicines Ltd | 465,000 | +0.0% | $133M | 2.7% |
| 10 | EWTX Edgewise Therapeutics Inc | 3.2M | −28.1% | $129M | 2.6% |
| 11 | RYTM Rhythm Pharmaceuticals Inc | 1.1M | +56.6% | $126M | 2.6% |
| 12 | LXRX Lexicon Pharmaceuticals Inc | 44.3M | +0.0% | $106M | 2.2% |
| 13 | ELVN Enliven Therapeutics Inc | 1.8M | +137.8% | $90M | 1.8% |
| 14 | SYRE Spyre Therapeutics Inc | 968,598 | +18.3% | $86M | 1.7% |
| 15 | PBLS Parabilis Medicines Inc | 3.0M | — | $82M | 1.7% |
| 16 | XENE Xenon Pharmaceuticals Inc | 1.3M | +0.0% | $80M | 1.6% |
| 17 | SLDB Solid Biosciences Inc | 7.7M | +0.0% | $77M | 1.6% |
| 18 | ABIVAX SA Abivax Sa | 576,000 | — | $77M | 1.6% |
| 19 | COAG Hemab Therapeutics Hldgs Inc | 2.1M | — | $77M | 1.6% |
| 20 | RCUS Arcus Biosciences Inc | 2.4M | −19.5% | $75M | 1.5% |
| 21 | COGT Cogent Biosciences Inc | 1.9M | +8.8% | $72M | 1.5% |
| 22 | RLAY Relay Therapeutics Inc | 3.6M | — | $68M | 1.4% |
| 23 | TSHA Taysha Gene Therapies Inc | 9.8M | +11.5% | $67M | 1.4% |
| 24 | DFTX Definium Therapeutics Inc | 1.4M | +54.4% | $67M | 1.4% |
| 25 | STOK Stoke Therapeutics Inc | 2.0M | +0.0% | $65M | 1.3% |
| 26 | IRON Disc Medicine Inc | 888,401 | −10.1% | $65M | 1.3% |
| 27 | CYTK Cytokinetics Inc | 758,952 | +23.6% | $65M | 1.3% |
| 28 | SEPN Septerna Inc | 1.9M | −5.0% | $64M | 1.3% |
| 29 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 4.9M | +2.1% | $61M | 1.2% |
| 30 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 1.4M | −25.4% | $53M | 1.1% |
| 31 | KLRA Kailera Therapeutics Inc | 2.2M | — | $49M | 1.0% |
| 32 | DYN Dyne Therapeutics Inc | 2.1M | −4.5% | $47M | 1.0% |
| 33 | GPCR Structure Therapeutics Inc | 872,967 | −34.3% | $47M | 0.9% |
| 34 | TBLA Taboola.Com Ltd | 8.4M | −15.5% | $42M | 0.9% |
| 35 | PVLA Palvella Therapeutics Inc Ne | 257,485 | +0.0% | $39M | 0.8% |
| 36 | SLN Silence Therapeutics Plc | 3.3M | +13.7% | $36M | 0.7% |
| 37 | DNLI Denali Therapeutics Inc | 1.4M | +0.0% | $36M | 0.7% |
| 38 | RELY Remitly Global Inc | 1.5M | +0.0% | $35M | 0.7% |
| 39 | CGEM Cullinan Therapeutics Inc | 1.9M | +58.7% | $34M | 0.7% |
| 40 | CAPITAL ONE FINL CORP Capital One Finl Corp | 171,615 | — | $34M | 0.7% |
| 41 | TRVI Trevi Therapeutics Inc | 1.8M | +0.0% | $33M | 0.7% |
| 42 | ORIC Oric Pharmaceuticals Inc | 3.0M | +0.0% | $32M | 0.7% |
| 43 | GOOGL Alphabet Inc | 90,000 | +37.0% | $32M | 0.7% |
| 44 | DBVT Dbv Technologies S A | 1.9M | +0.0% | $30M | 0.6% |
| 45 | ABSI Absci Corporation | 2.5M | +37.5% | $29M | 0.6% |
| 46 | SION Sionna Therapeutics Inc | 610,515 | +103.5% | $27M | 0.5% |
| 47 | RAPP Rapport Therapeutics Inc | 641,469 | +0.0% | $27M | 0.5% |
| 48 | AMLX Amylyx Pharmaceuticals Inc | 1.5M | +20.4% | $27M | 0.5% |
| 49 | ANNX Annexon Inc | 4.5M | +12.6% | $25M | 0.5% |
| 50 | MNPR Monopar Therapeutics Inc | 270,118 | +0.0% | $25M | 0.5% |